Michael D. Hooven, Director at AtriCure, Inc. (ATRC), bought 1,215 shares at $7.15 ($9K) on 2012-09-10, disclosed to the SEC on 2012-09-11.
Open-market purchase of $9k ATRC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.13 | 200 | $1K | 16.4% |
| 2 | $7.15 | 1,015 | $7K | 83.6% |
| Total | $7.15 avg | 1,215 | $9K | 100% |
| Filing → |
| ATRC | SELL | 2015-04-01 | $1.5M | — | Filing → |
| ATRC | SELL | 2015-01-02 | $577K | — | Filing → |
| ATRC | BUY | 2012-09-17 | $8K | — | Filing → |